249 related articles for article (PubMed ID: 16984595)
1. Kinetics of indocyanine green removal from blood can be used to predict the size of the area removed by radiofrequency ablation of hepatic nodules.
Sato S; Miyake T; Mishiro T; Furuta K; Azumi T; Oshima N; Takahashi Y; Rumi MA; Ishihara S; Adachi K; Amano Y; Kinoshita Y
J Gastroenterol Hepatol; 2006 Nov; 21(11):1714-9. PubMed ID: 16984595
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of indocyanine green retention rate with respect to complications of radiofrequency ablation in 878 patients with hepatocellular carcinoma.
Tang T; Feng X; Yan J; Xia F; Li X; Ma K; Bie P
Int J Hyperthermia; 2014 Sep; 30(6):402-7. PubMed ID: 25256893
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation alone versus radiofrequency ablation combined with chemoembolization in unresectable hepatocellular carcinoma.
Siriapisith T; Siwasattayanon P; Tongdee T
J Med Assoc Thai; 2012 Mar; 95(3):430-6. PubMed ID: 22550844
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapy.
Yamasaki T; Kurokawa F; Shirahashi H; Kusano N; Hironaka K; Okita K
Cancer; 2002 Dec; 95(11):2353-60. PubMed ID: 12436442
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.
Kawamura Y; Ikeda K; Seko Y; Hosaka T; Kobayashi M; Saitoh S; Kumada H
AJR Am J Roentgenol; 2011 Oct; 197(4):W665-73. PubMed ID: 21940538
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
7. Pattern and chronological change of iodized oil retention in radiofrequency ablation-induced vascular injury area: differentiation from iodized oil retention in recurrent hepatocellular carcinoma on computed tomography.
Lee JY; Kim YS; Rhim H; Lim HK; Choi D; Lee WJ
J Comput Assist Tomogr; 2010; 34(3):354-61. PubMed ID: 20498535
[TBL] [Abstract][Full Text] [Related]
8. [Value of postoperative indocyanine green retention rate at 15 minutes combined with standard remnant liver volume in predicting liver dysfunction after hepatectomy].
Mei L; Wang D; Li H; Li Z; Zhou L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 42(6):635-640. PubMed ID: 28690219
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma.
Feng K; Yan J; Li X; Xia F; Ma K; Wang S; Bie P; Dong J
J Hepatol; 2012 Oct; 57(4):794-802. PubMed ID: 22634125
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and feasibility of radiofrequency ablation for hepatocellular carcinoma patients.
Ge YS; Xu GL; Zhang CH; Jia WD; Li JS; Ma JL; Yu JH
Hepatogastroenterology; 2012; 59(120):2540-2. PubMed ID: 22510394
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness comparison of indocyanine green retention test with the cirrhotic severity scoring in evaluating the pathological severity of liver cirrhosis in patients with hepatocellular carcinoma and Child-Pugh grade A liver function.
Gu J; Zhang E; Liang B; Zhang Z; Chen X; Huang Z
World J Surg Oncol; 2020 Apr; 18(1):79. PubMed ID: 32326968
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the ability of Child-Pugh score, MELD score, and ICG-R15 to assess preoperative hepatic functional reserve in patients with hepatocellular carcinoma.
Wang YY; Zhao XH; Ma L; Ye JZ; Wu FX; Tang J; You XM; Xiang BD; Li LQ
J Surg Oncol; 2018 Sep; 118(3):440-445. PubMed ID: 30259515
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography-guided radiofrequency ablation of hepatocellular carcinoma: treatment efficacy and complications.
Laspas F; Sotiropoulou E; Mylona S; Manataki A; Tsagouli P; Tsangaridou I; Thanos L
J Gastrointestin Liver Dis; 2009 Sep; 18(3):323-8. PubMed ID: 19795027
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation--propensity score matching analysis.
Fukuda H; Numata K; Moriya S; Shimoyama Y; Ishii T; Nozaki A; Kondo M; Morimoto M; Maeda S; Sakamaki K; Morita S; Tanaka K
Radiology; 2014 Aug; 272(2):598-604. PubMed ID: 24689883
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous ultrasound-guided radiofrequency ablation (RFA) using saline-perfused (wet) needle electrodes for the treatment of hepatocellular carcinoma--long term experience.
Hänsler J; Frieser M; Tietz V; Uhlke D; Wissniowski TT; Bernatik T; Hahn EG; Strobel D
Ultraschall Med; 2007 Dec; 28(6):604-11. PubMed ID: 18074314
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence.
Murakami T; Ishimaru H; Sakamoto I; Uetani M; Matsuoka Y; Daikoku M; Honda S; Koshiishi T; Fujimoto T
Cardiovasc Intervent Radiol; 2007; 30(4):696-704. PubMed ID: 17497071
[TBL] [Abstract][Full Text] [Related]
17. Hepatic infarction after radiofrequency ablation of hepatocellular carcinoma with an internally cooled electrode.
Kim YS; Rhim H; Lim HK; Choi D; Lee WJ; Kim SH
J Vasc Interv Radiol; 2007 Sep; 18(9):1126-33. PubMed ID: 17804775
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous radiofrequency ablation with cooled electrodes combined with hepatic arterial balloon occlusion in hepatocellular carcinoma.
Yamasaki T; Kimura T; Kurokawa F; Aoyama K; Ishikawa T; Tajima K; Yokoyama Y; Takami T; Omori K; Kawaguchi K; Tsuchiya M; Terai S; Sakaida I; Okita K
J Gastroenterol; 2005 Feb; 40(2):171-8. PubMed ID: 15770401
[TBL] [Abstract][Full Text] [Related]
20. [Radiofrequency ablation for hepatocellular carcinoma and liver metastases].
Yasumoto T; Murakami T; Katsumoto Y; Hashimoto T; Noda S; Murata K; Kinuta M; Nakamura H
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1596-9. PubMed ID: 16315881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
